Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. Ohmachi
Ono-4059 (Gs-4059), a Next Generation BTK Inhibitor, Monotherapy in Patients With B-Cell Malignancies in the Japanese Phase 1, Dose-Escalation Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase Ii Study of THP (Pirarubicin)-Cop Therapy in Patients With Newly Diagnosed Advanced Ptcl: THP-3 Study of Japan Hematopoietic Malignancy Clinical Study Group
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement
SLAS Discovery
Biochemistry
Biotechnology
Analytical Chemistry
Molecular Medicine
Bruton Tyrosine Kinase Inhibitor ONO/GS-4059: From Bench to Bedside
Oncotarget
Oncology
Tanespimycin Monotherapy in Relapsed Multiple Myeloma: Results of a Phase 1 Dose-Escalation Study
British Journal of Haematology
Hematology
A Phase 1, Open-Label, Dose Escalation Study of Intravenous Paricalcitol in Combination With Gemcitabine in Patients With Advanced Malignancies
Cancer
Cancer Research
Oncology
Phase 1 Dose-Escalation Study of Single-Agent Veliparib in Japanese Patients With Advanced Solid Tumors
Cancer Science
Cancer Research
Medicine
Oncology
A First-In-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients With Advanced Solid Malignancies
Clinical Cancer Research
Cancer Research
Oncology
Phase 1 Dose-Escalation Study With LEC/Chtnt-3 and Toceranib Phosphate (Palladia) in Dogs With Spontaneous Malignancies
Journal of Cancer Science & Therapy
Preliminary Results of a Phase 1 Dose Escalation Study of the First-In-Class Anti-Cd74 Antibody Drug Conjugate (Adc), Stro-001, in Advanced B-Cell Malignancies
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination With Bevacizumab in Patients With Advanced Solid Malignancies
Clinical Cancer Research
Cancer Research
Oncology
